The observed increase in brain size (E) with body size (P) 'from mouse to elephant' may be described by a power relation E = kPb, where b is near 2/3 or 3/4. That this reflects a single, strong interaction between brain and body evolution is challenged by two observations: (1) different species with the same body size may have markedly different brain sizes, and (2) the value of b at the species level is usually nearer 1/3 than 2/3. Furthermore, the idea that a bigger brain means greater versatility on the part of its owner makes a strong statement about such animals. We examined these notions by measuring cranial volumes of 1,480 skulls from 62 subspecies of cricetid and murid rodents. Values of k and b were obtained by computing a reduced major axis on E and P across all specimens (b = 0.693), and when specimens were partitioned by genus (b̅ = 0.456) and subspecies level (b̅ = 0.338). Thus, the overall slope of 7/10 is not a simple extension of the developmental rules at the subspecies level (b near 1/3) nor even at the genus level (b near 4/9). Rather, it may reflect the most likely path for an interbreeding population subjected to varying selective pressures on one or more correlated traits. Furthermore, among the rodents studied, folivorous subspecies averaged about 2/3 as much brain as granivorous, insectivorous or generalist subspecies of the same body weight. Also, Old World rats, which may be more versatile than wood rats, gained their competitive advantage despite having relatively smaller brains.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.